CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-08 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Shares withheld for taxes | −3,183 | $26.77 | $85K | 268,744 |
| 2024-02-08 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Grant or award | +46,658 | 103,217 | ||
| 2024-02-08 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Shares withheld for taxes | −15,280 | $26.77 | $409K | 87,937 |
| 2024-02-08 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Grant or award | +28,240 | 156,190 | ||
| 2024-02-08 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −8,483 | $26.77 | $227K | 147,707 |
| 2024-02-08 | Brown Iain Michael SVP, Chief Financial Officer | Grant or award | +27,012 | 109,850 | ||
| 2024-02-08 | Brown Iain Michael SVP, Chief Financial Officer | Shares withheld for taxes | −8,137 | $26.77 | $218K | 101,713 |
| 2023-12-08 | LAURENCIN CATO T Director | Option exercise | +4,163 | 16,169 | ||
| 2023-12-08 | LAURENCIN CATO T Director | Shares withheld for taxes | −1,000 | $25.86 | $26K | 15,169 |
| 2023-12-08 | LAURENCIN CATO T Director | Option exercise · Restricted Stock Unit Award | −4,163 | 4,163 | ||
| 2023-11-17 | Wright Christopher I Director | Other acquisition · Non Qualified Stock Option (Right to Buy) | +14 | $28.40 | $398 | 728 |
| 2023-11-17 | Wright Christopher I Director | Other acquisition · Non Qualified Stock Option (Right to Buy) | +355 | $28.40 | $10K | 18,128 |
| 2023-11-17 | Wright Christopher I Director | Other acquisition · Restricted Stock Unit Award | +129 | 6,602 | ||
| 2023-11-17 | Wright Christopher I Director | Other acquisition · Non Qualified Stock Option (Right to Buy) | +231 | $30.86 | $7K | 11,785 |
| 2023-11-17 | Wright Christopher I Director | Other acquisition · Non Qualified Stock Option (Right to Buy) | +254 | $30.72 | $8K | 12,986 |
| 2023-11-17 | Wright Christopher I Director | Other acquisition · Restricted Stock Unit Award | +119 | 6,104 | ||
| 2023-11-17 | Wilson Frank Anders Director | Other acquisition · Non Qualified Stock Option (Right to Buy) | +1,236 | $20.81 | $26K | 63,036 |
| 2023-11-17 | Wilson Frank Anders Director | Other acquisition · Non Qualified Stock Option (Right to Buy) | +224 | $20.81 | $5K | 11,424 |
| 2023-11-17 | Wilson Frank Anders Director | Other acquisition · Non Qualified Stock Option (Right to Buy) | +256 | $16.52 | $4K | 13,079 |
| 2023-11-17 | Wilson Frank Anders Director | Other acquisition · Non Qualified Stock Option (Right to Buy) | +230 | $18.45 | $4K | 11,739 |
Page 30 of 41 · 804 trades